PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
Authors
Keywords
-
Journal
ONCOGENE
Volume 41, Issue 33, Pages 4003-4017
Publisher
Springer Science and Business Media LLC
Online
2022-07-08
DOI
10.1038/s41388-022-02391-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer
- (2021) Yinan Xiao et al. ONCOGENE
- Context-dependent roles of YAP/TAZ in stem cell fates and cancer
- (2021) Lucy LeBlanc et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Quinacrine-Induced Autophagy in Ovarian Cancer Triggers Cathepsin-L Mediated Lysosomal/Mitochondrial Membrane Permeabilization and Cell Death
- (2021) Prabhu Thirusangu et al. Cancers
- A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations
- (2020) Hirohito Yamaguchi et al. Frontiers in Oncology
- Metabolic Adaptations in Cancer Stem Cells
- (2020) Umesh Prasad Yadav et al. Frontiers in Oncology
- Energy metabolism in cancer stem cells
- (2020) Xuan Zhu et al. World Journal of Stem Cells
- BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling
- (2019) Sachin Verma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses
- (2019) Sayantani Sarkar Bhattacharya et al. Cell Death & Disease
- Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer
- (2018) DeokBeom Jung et al. Scientific Reports
- YAP/TAZ Activation as a Target for Treating Metastatic Cancer
- (2018) Janine Warren et al. Cancers
- Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?
- (2018) Angel Qin et al. Journal of Oncology Practice
- Managing Patients With Relapsed Small-Cell Lung Cancer
- (2018) Jun Gong et al. Journal of Oncology Practice
- Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
- (2018) Susmita Mondal et al. INTERNATIONAL JOURNAL OF CANCER
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma
- (2017) Hui-Min Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- The molecular basis of targeting PFKFB3 as a therapeutic strategy against cancer
- (2017) Luo Lu et al. Oncotarget
- Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance
- (2017) Lukas Klameth et al. Scientific Reports
- BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation
- (2016) Prabhu Thirusangu et al. ANGIOGENESIS
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Lung cancer stem cells: The root of resistance
- (2016) Lauren MacDonagh et al. CANCER LETTERS
- Characterization of Hippo Pathway Components by Gene Inactivation
- (2016) Steven W. Plouffe et al. MOLECULAR CELL
- Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
- (2016) Fuqin Fan et al. Science Translational Medicine
- YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells
- (2016) Yuyuan Dai et al. Oncotarget
- Management of Small Cell Lung Cancer
- (2015) Mehmet Altan et al. CANCER JOURNAL
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis
- (2014) B.R. Vijay Avin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells
- (2014) Oleksandr H Minchenko WORLD JOURNAL OF GASTROENTEROLOGY
- Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2
- (2013) Feng Yin et al. CELL
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression
- (2011) Takeo Nakanishi et al. Chinese Journal of Cancer
- ABC Transporters as Potential Targets for Modulation of Drug Resistance
- (2009) L. Gatti et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
- (2009) F. Jiang et al. MOLECULAR CANCER RESEARCH
- Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy
- (2008) Kohji Noguchi et al. ADVANCED DRUG DELIVERY REVIEWS
- Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer
- (2008) Jianhui Yuan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search